Prana Completes Phase 2 Huntington Disease Trial with PBT2
Filed with ASX ·
6ix hasn’t read this filing yet.
Alterity Therapeutics Ltd. on 6ix
Earlier from Alterity Therapeutics
- Prana Updates Progress on PBT2 Trials
- Pranas PBT2 Reverses Memory Loss in Normal Aging
- Prana Provides Update on Clinical Trials for Alzheimers
- Prana completes PBT2 dosing in IMAGINE AD Trial
- Parkinsons UK Awards GBP150,000 to Study Pranas PBT434
Later from Alterity Therapeutics
All Alterity Therapeutics news releasesFollow Alterity Therapeutics into a list and get an email when it puts out news.
Follow Alterity Therapeutics